Czech National Bank Buys 1,567 Shares of The Clorox Company (NYSE:CLX)

Czech National Bank raised its position in shares of The Clorox Company (NYSE:CLX) by 6.6% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 25,232 shares of the company’s stock after acquiring an additional 1,567 shares during the period. Czech National Bank’s holdings in Clorox were worth $4,111,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Innealta Capital LLC bought a new stake in Clorox in the 2nd quarter valued at $30,000. Trifecta Capital Advisors LLC boosted its position in shares of Clorox by 139.8% in the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after acquiring an additional 130 shares during the period. GoalVest Advisory LLC acquired a new position in shares of Clorox in the first quarter valued at about $31,000. First Foundation Advisors bought a new position in Clorox during the first quarter worth about $31,000. Finally, Family Firm Inc. acquired a new stake in Clorox in the 2nd quarter worth about $31,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Performance

Shares of Clorox stock opened at $161.57 on Monday. The company’s 50 day moving average price is $154.91 and its two-hundred day moving average price is $144.39. The firm has a market capitalization of $20.07 billion, a P/E ratio of 83.72, a P/E/G ratio of 3.31 and a beta of 0.41. The Clorox Company has a fifty-two week low of $114.68 and a fifty-two week high of $169.09. The company has a debt-to-equity ratio of 5.04, a current ratio of 1.03 and a quick ratio of 0.63.

Clorox (NYSE:CLX) last released its quarterly earnings data on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, beating the consensus estimate of $1.54 by $0.28. Clorox had a return on equity of 281.12% and a net margin of 3.95%. The company had revenue of $1.90 billion for the quarter, compared to the consensus estimate of $1.97 billion. On average, equities analysts forecast that The Clorox Company will post 6.63 earnings per share for the current fiscal year.

Clorox Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be paid a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.02%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s dividend payout ratio is currently 252.85%.

Insider Activity at Clorox

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares of the company’s stock, valued at $2,229,719.92. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.51% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

CLX has been the topic of several recent research reports. Wells Fargo & Company lowered their target price on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating on the stock in a report on Wednesday, July 10th. Citigroup lifted their price objective on Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a report on Friday, September 6th. Deutsche Bank Aktiengesellschaft increased their target price on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. DA Davidson reaffirmed a “neutral” rating and issued a $153.00 price target on shares of Clorox in a research note on Friday, September 6th. Finally, Jefferies Financial Group upgraded shares of Clorox from a “hold” rating to a “buy” rating and increased their price objective for the stock from $174.00 to $187.00 in a research note on Tuesday, October 1st. Six equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, Clorox currently has a consensus rating of “Hold” and an average price target of $146.13.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.